Diversify Wealth Management LLC Has $1.23 Million Stock Holdings in STERIS plc (NYSE:STE)

Diversify Wealth Management LLC increased its holdings in shares of STERIS plc (NYSE:STE) by 42.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,994 shares of the medical equipment provider’s stock after acquiring an additional 1,772 shares during the period. Diversify Wealth Management LLC’s holdings in STERIS were worth $1,233,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Ashton Thomas Securities LLC acquired a new stake in shares of STERIS during the third quarter worth approximately $25,000. Central Pacific Bank Trust Division bought a new stake in shares of STERIS during the third quarter worth $28,000. Quarry LP acquired a new stake in shares of STERIS in the third quarter valued at $67,000. Asset Dedication LLC raised its holdings in shares of STERIS by 54.8% in the third quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock valued at $71,000 after buying an additional 103 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in STERIS by 45.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 583 shares of the medical equipment provider’s stock worth $139,000 after buying an additional 181 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on STE shares. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Stephens reiterated an “overweight” rating and issued a $260.00 price objective on shares of STERIS in a research report on Thursday, November 7th. Piper Sandler upgraded STERIS from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Monday, November 18th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, November 8th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $262.50.

STERIS Trading Down 0.3 %

NYSE STE opened at $209.50 on Tuesday. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The company has a market capitalization of $20.68 billion, a PE ratio of 47.83 and a beta of 0.84. The stock has a 50-day simple moving average of $211.79 and a 200 day simple moving average of $224.77.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.12 by $0.02. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the previous year, the business earned $2.03 EPS. The firm’s revenue was up 7.3% on a year-over-year basis. Research analysts forecast that STERIS plc will post 9.1 EPS for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th were given a dividend of $0.57 per share. The ex-dividend date was Tuesday, November 19th. This represents a $2.28 annualized dividend and a dividend yield of 1.09%. STERIS’s dividend payout ratio is currently 52.05%.

Insider Buying and Selling

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the sale, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at $2,471,363.04. The trade was a 12.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 1.14% of the stock is owned by corporate insiders.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.